Sally J. Aldous

Jun 14, 2024 | bmjopen.bmj.com | John Pickering |Gerard P. Devlin |Richard Body |Sally J. Aldous

Intervention-evaluation phaseIn the intervention phase, the only modification to the decision-making logic of existing usual-care clinical pathways is the use of a POC-cTnI measurement within the ED in place of the central laboratory hs-cTn measurement. The intervention will remain in place in all sites for a minimum 4 months following the end of the run-in period at the final site(s). POC-TnI will be the preferential troponin test used in the ED instead of central laboratory cTn testing.

Apr 22, 2024 | emj.bmj.com | John Pickering |Laura Hamill |Sally J. Aldous |Laura R Joyce

Handling editor Richard BodyX @laurajoycenzContributors JP, MT and LJ provided scientific advice and authorship. LH, SA and CMF provided scientific analysis and advice. RAS and OW collected and collated data. Funding Health Research Council of New Zealand grant 19-234. Siemens Healthineers provided the assay kits free of charge and funding for the adjudicator. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed.

Mar 1, 2024 | emj.bmj.com | John Pickering |Laura Hamill |Sally J. Aldous |Laura R Joyce

Handling editor Richard BodyTwitter @laurajoycenzContributors JP, MT and LJ provided scientific advice and authorship. LH, SA and CMF provided scientific analysis and advice. RAS and OW collected and collated data. Funding Health Research Council of New Zealand grant 19-234. Siemens Healthineers provided the assay kits free of charge and funding for the adjudicator. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed.